Profile Photo
Elizabeth Winzeler

Elizabeth Winzeler

Title(s)
Professor of Pediatrics
Director of Translational Research, UC Health Sciences Center for Immunology, Infection and Inflammation


Pathways and Processes
Any
Approaches
Genetics, genomics, sequencing, microarrays, chemical genetics, drug discovery, bio and cheminformatics
Diseases
Neglected diseases, infectious diseases

My laboratory has traditionally used "big data" approaches to solve problems in public health at the molecular level. We have created and evaluated large chemical screening datasets to help create new drug candidates for the treatment of malaria. We are using comprehensive whole genome sequencing approaches to find novel drug targets, and we are using genomics to find genes involved in pathogen drug resistance.

 

Faculty Spotlight:

Elizabeth Winzeler, professor in the Department of Pediatrics at UC San Diego School of Medicine, and associate dean for research and innovation at UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, is an expert in drug development. Her lab studies how diseases interact with the human body, using data-intensive methods to find solutions, often by looking at how different chemicals affect infections and by analyzing the complete DNA of organisms. Author of more than 250 publications, Winzeler is also a member of the National Academy of Medicine and fellow of the American Academy of Microbiology. She has received numerous recognitions for her research including the Keck New Investigator Award and Ellison Medical Foundation New Scholars Award, Bailey K. Ashford Medal for distinguished achievements in tropical medicine, Alice and C.C. Wang Award in Molecular Parasitology and Project of the Year from the Medicines for Malaria Venture. For more than 20 years, the main focus of her research has centered on developing better medications for the treatment and eradication of malaria. She worked with the Bill and Melinda Gates Foundation to establish and direct what has become the Malaria Drug Accelerator (MalariaDA.org), a consortium of 18 laboratories in the United States, Africa, Europe and Asia working to improve and accelerate antimalarial drug discovery processes.